Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Most linked-to pages

From GxPlex

Jump to: navigation, search

Showing below up to 50 results in range #301 to #350.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 73 Paragraph 5 (7 links)
  2. Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 76 Paragraph 1 (7 links)
  3. Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 77 Paragraph 4 – 5 (7 links)
  4. Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 82 Paragraph 3 – 5 (7 links)
  5. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 ANNEX III Section 2.1 (7 links)
  6. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 ANNEX I Section D No.17 ; No. 22 (7 links)
  7. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 ANNEX I Section D No. 17 (7 links)
  8. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 ANNEX I Section D No. 19 (7 links)
  9. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 ANNEX VI Section 2.5 No. 17-22 (7 links)
  10. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 29 Paragraph 1 (7 links)
  11. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 3 (7 links)
  12. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 32 Paragraph 1 (7 links)
  13. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 37 Paragraph 1 – 7 (7 links)
  14. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 37 Paragraph 4 (7 links)
  15. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 38 (7 links)
  16. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 41-001 (7 links)
  17. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 41-002 (7 links)
  18. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 42 (7 links)
  19. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 43 (7 links)
  20. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 47-001 (7 links)
  21. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 48 (7 links)
  22. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 51 (7 links)
  23. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 53 (7 links)
  24. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 54 (7 links)
  25. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 56 (7 links)
  26. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 57 (7 links)
  27. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 58 (7 links)
  28. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 66 (7 links)
  29. Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 67 (7 links)
  30. Reference:FRA AEC DOC010 V.04 01-Jun-2018 - (7 links)
  31. Reference:FRA AEC DOC012 v03 Avis aux promoteurs d’investigations cliniques de DM (RIPH1) – Partie II 16-May-2025 2.-001 (7 links)
  32. Reference:FRA AEC DOC012 v03 Avis aux promoteurs d’investigations cliniques de DM (RIPH1) – Partie II 16-May-2025 2.-002 (7 links)
  33. Reference:FRA Bonnes pratiques - CONTRÔLE QUALITÉ À DISTANCE DES ESSAIS CLINIQUES (CNIL) 16-May-2024 - (7 links)
  34. Reference:FRA SURV VIG DOC118 V01 REC-Avis aux promoteurs -Partie V 16-May-2025 5. (7 links)
  35. Reference:GBR Clinical investigations of medical devices – compiling a submission to MHRA May 2021 2.-001 (7 links)
  36. Reference:GBR Clinical investigations of medical devices – compiling a submission to MHRA May 2021 2.-002 (7 links)
  37. Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 10 (b)-001 (7 links)
  38. Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 10 (b)-002 (7 links)
  39. Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 10 (c) (7 links)
  40. Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 16 (7 links)
  41. Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (p) (7 links)
  42. Reference:GBR Directive 93/42/EEC 11-Oct-2007 ANNEX X 2.1 (7 links)
  43. Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex VIII 1. ; 2. (7 links)
  44. Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex X (7 links)
  45. Reference:GBR Directive 93/42/EEC 11-Oct-2007 Article 15 1. - 4. (7 links)
  46. Reference:GBR Directive 93/42/EEC 11-Oct-2007 Article 15 6. - 7.-001 (7 links)
  47. Reference:GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 D Investigator/Institution (7 links)
  48. Reference:GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 D Who should notify (7 links)
  49. Reference:GBR Guidance Access to Electronic Health Records by Sponsor representatives in clinical trials 44447 - (7 links)
  50. Reference:GBR Guidance Access to Electronic Health Records by Sponsor representatives in clinical trials 44447 System Security (7 links)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://gxplex.org/index.php?title=Special:MostLinkedPages"